Clinical Trial Update: To Evaluate the Safety, Tolerability, and Preliminary Antitumor Activity of STR-P004 [NA]

View source ↗

Summary

A clinical trial update outlines evaluating STR-P004 for safety, tolerability, and preliminary antitumor activity in acute lymphoblastic leukemia, with the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• STR-P004

Snippet

Sponsor: Starna Therapeutics | Conditions: Acute Lymphobkastic Leukemia | NA | Status: NOT_YET_RECRUITING